ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OTLK Outlook Therapeutics Inc

7.55
0.00 (0.00%)
Pre Market
Last Updated: 07:00:13
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -18.92M-17.04M-14M-15.67M-6.86M-18.15M-12.47M-10.32M
Pre Tax Income -19.7M-17.54M-14.34M-18.66M-6.65M-20.68M-12.99M-11.18M
Net Income -19.7M-17.54M-14.35M-18.66M-6.65M-20.68M-12.99M-11.18M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -18.92M-17.92M-14M-15.67M-6.86M-21.06M-13.31M-11.31M
EBITDA -18.87M-16.97M-13.98M-15.66M-6.84M-18.14M-12.46M-10.29M
Year End September 29 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.98M3.81M3.09M8.15M0000
Operating Income -51.76M-35.88M-29.64M-36.3M-36.84M-51.77M-63.12M-53.14M
Pre Tax Income -53.23M-38.35M-33.74M-37.94M-38.51M-53.16M-66.05M-58.98M
Net Income -63.17M-40.03M-48.02M-36.04M-48.87M-53.16M-66.05M-58.98M
Preferred Dividends 000-625k-10.5M000
Basic Earnings Per Share (EPS) -2.77-1.605-0.665-1.26-0.384-0.301-0.291-0.227
EBIT -51.76M-35.88M-30.9M-36.91M-36.94M-51.77M-64M-56.89M
EBITDA -49.36M-33.19M-26.59M-21.67M-36.09M-51.61M-62.96M-53.09M